Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;25(7):1771-7.
doi: 10.1007/s11136-015-1211-4. Epub 2015 Dec 22.

Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation

Rui V Duarte  1 , Lazaros Andronis  2 , Mathieu W P M Lenders  3 , Cecile C de Vos  3   4
Affiliations

Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation

Rui V Duarte et al. Qual Life Res. 2016 Jul.

Abstract

Purpose: This study aims to explore the changes in pain intensity and quality of life (QoL) experienced by patients with painful diabetic neuropathy (PDN) treated with spinal cord stimulation (SCS) and conventional medical practice (CMP).

Methods: Patient-reported pain intensity and QoL data were obtained from participants in an international multicentre randomised controlled trial comparing SCS versus CMP. Data were collected at randomisation and 6 month follow up by means of a visual analogue scale for pain intensity, the EuroQoL Visual Analogue Scale (EQ VAS) and the EuroQol EQ-5D index. Quality-adjusted life years (QALYs) were calculated for each treatment using the 'area under the curve' method. Differences in QALYs were calculated after adjusting for between-treatment imbalances in baseline QoL.

Results: At 6 months, patients allocated to SCS reported larger reductions in pain intensity and improvements in QoL measured by the EQ-5D utility score and EQ VAS as compared to those allocated to CMP. Initial calculations of QALYs for the SCS and CMP groups suggested no statistical differences between the groups. Adjusting for imbalances in baseline EQ-5D scores showed SCS to be associated with significantly higher QALYs compared to CMP.

Conclusions: SCS resulted in significant improvement in pain intensity and QoL in patients with PDN, offering further support for SCS as an effective treatment for patients suffering from PDN. From a methodological point of view, different results would have been obtained if QALY calculations were not adjusted for baseline EQ-5D scores, highlighting the need to account for imbalances in baseline QoL.

Keywords: EuroQoL-5D; Neuropathic pain; Painful diabetic neuropathy; Quality of life; Spinal cord stimulation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
EQ-5D index scores for SCS and CMP at baseline and 6 months follow-up. CMP conventional medical practice; SCS spinal cord stimulation
Fig. 2
Fig. 2
Comparison of the EQ-5D subcategories in CMP and SCS groups at baseline and 6 month follow-up. CMP conventional medical practice; SCS spinal cord stimulation
See this image and copyright information in PMC

References

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi: 10.2337/diacare.27.5.1047. - DOI - PubMed
    1. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522. doi: 10.2337/dc05-2228. - DOI - PubMed
    1. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care. 2011;34(10):2220–2224. doi: 10.2337/dc11-1108. - DOI - PMC - PubMed
    1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635. doi: 10.1212/01.wnl.0000282763.29778.59. - DOI - PubMed
    1. Meyer-Rosberg K, Burckhardt CS, Huizar K, Kvarnström A, Nordfors LO, Kristofferson A. A comparison of the SF-36 and Nottingham health profile in patients with chronic neuropathic pain. European Journal of Pain. 2001;5(4):391–403. doi: 10.1053/eujp.2001.0260. - DOI - PubMed